| Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults A Restar, EJ Dusic, H Garrison-Desany, E Lett, A Everhart, KE Baker, ... Humanities and Social Sciences Communications 9 (1), 1-11, 2022 | 17 | 2022 |
| Barriers, interventions, and recommendations: Improving the genetic testing landscape EJ Dusic, T Theoryn, C Wang, EM Swisher, DJ Bowen, EDGE Study Team Frontiers in Digital Health 4, 961128, 2022 | 14 | 2022 |
| Mapping community-engaged implementation strategies with transgender scientists, stakeholders, and trans-led community organizations A Restar, BJ Minalga, MI Quilantang, T Adamson, E Dusic, ... Current HIV/AIDS Reports 20 (3), 160-169, 2023 | 10 | 2023 |
| Socioeconomic status and interest in genetic testing in a US-based sample EJ Dusic, DJ Bowen, R Bennett, KC Cain, T Theoryn, M Velasquez, ... Healthcare 10 (5), 880, 2022 | 10 | 2022 |
| Making it to sustainability: Evaluating billing strategies for Collaborative Care D Chang, DJ Morrison, DJ Bowen, HM Harris, EJ Dusic, MB Velasquez, ... Psychiatric Services 74 (11), 1192-1195, 2023 | 2 | 2023 |
| Cascade genetic testing for Lynch syndrome: current understanding, challenges, and emerging opportunities DJ Bowen, EJ Dusic, S Makhnoon Medical Research Archives 10 (2), 2022 | 1 | 2022 |
| A Narrative Synthesis Review of Legislation Banning Gender-Affirming Care JM Garcia Gutiérrez, E Dusic, AJK Bambilla, AJ Restar Current Pediatrics Reports, 1-8, 2024 | | 2024 |
| Policy and laboratory practice: How quality control procedures for genetic testing perpetuate biological essentialism and discrimination against transgender, gender diverse … EJ Dusic, LN Powers, SV Clowes Candadai, SM Fullerton Journal of Genetic Counseling, 2024 | | 2024 |
| Abstract LB232: Implementation of population-based risk assessment for hereditary cancer in primary care: Results from the Early Detection of Genetic Risk (EDGE) Trial EM Swisher, HM Harris, BM Norquist, J Brant, B Shirts, S Knerr, EJ Dusic, ... Cancer Research 84 (7_Supplement), LB232-LB232, 2024 | | 2024 |
| Structural and Social Inclusivity of Transgender and Nonbinary Students in US Medical Schools and Schools of Public Health Programming GGB Gonzalez, EJ Dusic, D Operario, MB Velasquez, A Restar Transgender Health, 2024 | | 2024 |
| Epidemiological Overview of Mental Health Outcomes Among Transgender, Nonbinary, and/or Gender-Expansive (TNG) People AJ Restar, EJ Dusic, R Aguayo-Romero, SL Reisner Gender-Affirming Psychiatric Care, 1, 2023 | | 2023 |
| Current Generation of Trans Leaders and Hero Activists R Lucas, E Dusic, JM Garcia Gutiérrez, A Restar Encyclopedia of Heroism Studies, 1-6, 2023 | | 2023 |
| WITHDRAWN: A Quality Improvement Study Evaluating Implementation of Collaborative Care Code Billing D Chang, D Morrison, D Bowen, H Harris, E Dusic, MB Velasquez, ... | | 2022 |
| Barriers, interventions, and recommendations: Improving the genetic testing landscape B Schooley, S Narod, EJ Dusic, EJ Dusic, T Theoryn, C Wang, ... | | 2022 |
| Status socioeconômico e interesse em buscar testes genéticos para câncer hereditário em uma população baseada nos EUA EJ Dusic | | 2021 |
| Socioeconomic Status and Interest in Pursuing Genetic Testing for Hereditary Cancer in a US Based Population EJ Dusic University of Washington, 2021 | | 2021 |
